- Category
- Micro (2023-24)
- Udyam number
- UDYAM-PY-03-0016229

Prosilio Pharmaceuticals Private Limited
About Prosilio Pharmaceuticals Private Limited
Data last updated:
Prosilio Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74999TN2018PTC125144. Its GSTIN is 34AAKCP1263B1ZT (Puducherry).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nilavoli and Mukeshmani Dhatchayani.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.29/F1 (Old No.12/F1) A – Block Chakra Flats Sriramapuram 1st Street, Chennai, Tamil Nadu, India – 600094.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.08 Cr, a decline of 10% compared to the previous year. For the same year it recorded a net profit of ₹1.89 Lakh (net margin 0.6%) and EBITDA of ₹3.12 Lakh (EBITDA margin 1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years.
Court records list 2 cases involving the company, including 2 filed against it.
Prosilio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0016229).
Company details
Recognitions & Rankings of Prosilio Pharmaceuticals
Contact details
Prosilio Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo.29/F1 (Old No.12/F1) A – Block Chakra Flats Sriramapuram 1st Street, Chennai, Tamil Nadu, India – 600094
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Prosilio Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Prosilio Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Prosilio Pharmaceuticals Private Limited, buy the company report.
Financials of Prosilio Pharmaceuticals Private Limited
FY 2024 filings availableProsilio Pharmaceuticals Private Limited reported revenue of ₹3.08 Cr (down 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 10% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.89 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Prosilio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Prosilio Pharmaceuticals Private Limited
Prosilio Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilavoli | Director | 27 Jul 2020 | 6 Years 3 Months | Current |
| Mukeshmani Dhatchayani | Director | 05 Oct 2018 | 8 Years 1 Months | Current |
Auditor
Prosilio Pharmaceuticals Private Limited is audited by L. ALBERT KARUNAKARAN for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| L. ALBERT KARUNAKARAN | FY 2023 | 216635 |
Shareholding
The shareholding of Prosilio Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Prosilio Pharmaceuticals Private Limited, buy the company report.
Legal cases
Prosilio Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Puducherry | Motor accident claim | Filed against the company by an individual | Disposed |
To see the full case history of Prosilio Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Prosilio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Prosilio Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 34AAKCP1263B1ZT | Puducherry | Active | 29 Jan 2019 |
To see the full GST registrations and return filing status of Prosilio Pharmaceuticals Private Limited, buy the company report.
Recent activity
Prosilio Pharmaceuticals Private Limited has 4 board changes on record since 2018: 2 appointments and 2 cessations. The latest: Nilavoli ceased to be Additional Director on 30 Nov 2021.
Frequently asked questions
Prosilio Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 October 2018 (8+ years old) and is registered under CIN U74999TN2018PTC125144.
Prosilio Pharmaceuticals has 2 current directors:
- Nilavoli - Director
- Mukeshmani Dhatchayani - Director
The latest financial statements of Prosilio Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Prosilio Pharmaceuticals is 34AAKCP1263B1ZT, registered in Puducherry.
The CIN (Corporate Identification Number) of Prosilio Pharmaceuticals is U74999TN2018PTC125144. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Prosilio Pharmaceuticals has 2 court cases on record: 2 filed against it.
Prosilio Pharmaceuticals was incorporated on 05 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Chennai.
Nilavoli ceased to be Additional Director on 30 Nov 2021. Nilavoli was appointed as Director on 27 Jul 2020. Mathivanan Sundaramoorthy ceased to be Director on 10 Oct 2018. Prosilio Pharmaceuticals has 4 board changes on record in total.
Yes, Prosilio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-PY-03-0016229).
The registered office of Prosilio Pharmaceuticals is at No.29F1 Old No.12F1 A – Block Chakra Flats Sriramapuram 1st Street, Chennai, Tamil Nadu, India – 600094.

